7:00 PM
 | 
Feb 07, 2013
 |  BC Extra  |  Company News

Addex refocusing pipeline, reducing Geneva operations

Addex Therapeutics Ltd. (SIX:ADXN) said it plans to reduce the size of its operations in Geneva and its early-stage discovery efforts to focus its resources on developing its pipeline for rare diseases. The company also said it will pursue a listing on a U.S....

Read the full 202 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >